nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—osteoporosis	0.166	1	CbGaD
Equilin—Estropipate—osteoporosis	0.133	0.328	CrCtD
Equilin—Conjugated Estrogens—osteoporosis	0.101	0.249	CrCtD
Equilin—Estradiol—osteoporosis	0.0865	0.214	CrCtD
Equilin—Ethinyl Estradiol—osteoporosis	0.0845	0.209	CrCtD
Equilin—SHBG—Estropipate—osteoporosis	0.0797	0.485	CbGbCtD
Equilin—SHBG—Ethinyl Estradiol—osteoporosis	0.0514	0.313	CbGbCtD
Equilin—SHBG—Estradiol—osteoporosis	0.0331	0.202	CbGbCtD
Equilin—Estriol—Estropipate—osteoporosis	0.0198	0.0811	CrCrCtD
Equilin—Conjugated Estrogens—Estropipate—osteoporosis	0.0169	0.069	CrCrCtD
Equilin—Estriol—Conjugated Estrogens—osteoporosis	0.015	0.0614	CrCrCtD
Equilin—Dezocine—Estradiol—osteoporosis	0.0142	0.0581	CrCrCtD
Equilin—Estriol—Estradiol—osteoporosis	0.0129	0.0529	CrCrCtD
Equilin—Estropipate—Conjugated Estrogens—osteoporosis	0.0128	0.0523	CrCrCtD
Equilin—Estriol—Ethinyl Estradiol—osteoporosis	0.0126	0.0516	CrCrCtD
Equilin—Estradiol—Estropipate—osteoporosis	0.0125	0.0512	CrCrCtD
Equilin—Estrone—Estropipate—osteoporosis	0.0125	0.0512	CrCrCtD
Equilin—Ethinyl Estradiol—Estropipate—osteoporosis	0.0119	0.0487	CrCrCtD
Equilin—Conjugated Estrogens—Estradiol—osteoporosis	0.011	0.045	CrCrCtD
Equilin—Estropipate—Estradiol—osteoporosis	0.011	0.045	CrCrCtD
Equilin—Conjugated Estrogens—Ethinyl Estradiol—osteoporosis	0.0107	0.044	CrCrCtD
Equilin—Estropipate—Ethinyl Estradiol—osteoporosis	0.0107	0.044	CrCrCtD
Equilin—Estradiol—Conjugated Estrogens—osteoporosis	0.00948	0.0388	CrCrCtD
Equilin—Estrone—Conjugated Estrogens—osteoporosis	0.00948	0.0388	CrCrCtD
Equilin—HSD17B1—Estrogen biosynthesis—CYP19A1—osteoporosis	0.00932	0.49	CbGpPWpGaD
Equilin—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.00903	0.0369	CrCrCtD
Equilin—Estrone—Estradiol—osteoporosis	0.00816	0.0334	CrCrCtD
Equilin—Estradiol—Ethinyl Estradiol—osteoporosis	0.00796	0.0326	CrCrCtD
Equilin—Estrone—Ethinyl Estradiol—osteoporosis	0.00796	0.0326	CrCrCtD
Equilin—Ethinyl Estradiol—Estradiol—osteoporosis	0.00777	0.0318	CrCrCtD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00099	0.0521	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000595	0.0313	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000336	0.0177	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000319	0.0168	CbGpPWpGaD
Equilin—Conjugated Estrogens—SLC51A—osteoporosis	0.000289	0.163	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000248	0.013	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000242	0.0127	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000193	0.0102	CbGpPWpGaD
Equilin—HSD17B1—Disease—SOST—osteoporosis	0.000179	0.0094	CbGpPWpGaD
Equilin—HSD17B1—Disease—PKM—osteoporosis	0.000179	0.0094	CbGpPWpGaD
Equilin—Estriol—ESR2—osteoporosis	0.00017	0.0959	CrCbGaD
Equilin—HSD17B1—Disease—ANTXR2—osteoporosis	0.00017	0.00891	CbGpPWpGaD
Equilin—HSD17B1—Disease—PGLS—osteoporosis	0.00017	0.00891	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000164	0.00864	CbGpPWpGaD
Equilin—Estriol—SHBG—osteoporosis	0.000155	0.0875	CrCbGaD
Equilin—HSD17B1—Metabolism—PKM—osteoporosis	0.00015	0.00788	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FDPS—osteoporosis	0.00015	0.00788	CbGpPWpGaD
Equilin—HSD17B1—Disease—GSN—osteoporosis	0.000144	0.00758	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPD2—osteoporosis	0.000142	0.00747	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PGLS—osteoporosis	0.000142	0.00747	CbGpPWpGaD
Equilin—Estropipate—ESR2—osteoporosis	0.00013	0.0733	CrCbGaD
Equilin—HSD17B1—Metabolism—PNP—osteoporosis	0.00013	0.00683	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ATIC—osteoporosis	0.00013	0.00683	CbGpPWpGaD
Equilin—HSD17B1—Disease—LRP5—osteoporosis	0.000125	0.00659	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOST—osteoporosis	0.000125	0.00659	CbGpPWpGaD
Equilin—HSD17B1—Disease—LRP6—osteoporosis	0.00012	0.00631	CbGpPWpGaD
Equilin—Estropipate—SHBG—osteoporosis	0.000119	0.0669	CrCbGaD
Equilin—HSD17B1—Disease—RPL24—osteoporosis	0.000115	0.00606	CbGpPWpGaD
Equilin—HSD17B1—Disease—LTF—osteoporosis	0.000115	0.00606	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTH1R—osteoporosis	0.000113	0.00596	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CALCR—osteoporosis	0.000113	0.00596	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—OXCT1—osteoporosis	0.00011	0.00581	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CA2—osteoporosis	0.00011	0.00581	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MGLL—osteoporosis	0.000108	0.00566	CbGpPWpGaD
Equilin—Estriol—ESR1—osteoporosis	0.000105	0.0591	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000101	0.00534	CbGpPWpGaD
Equilin—HSD17B1—Disease—ACP5—osteoporosis	9.99e-05	0.00525	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR2—osteoporosis	9.29e-05	0.0524	CrCbGaD
Equilin—HSD17B1—Disease—TPI1—osteoporosis	9.29e-05	0.00488	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—IDH2—osteoporosis	9.15e-05	0.00481	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MGLL—osteoporosis	9e-05	0.00473	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LRP5—osteoporosis	8.78e-05	0.00462	CbGpPWpGaD
Equilin—HSD17B1—Disease—P4HB—osteoporosis	8.73e-05	0.00459	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP27A1—osteoporosis	8.6e-05	0.00452	CbGpPWpGaD
Equilin—HSD17B1—Disease—GAPDH—osteoporosis	8.57e-05	0.00451	CbGpPWpGaD
Equilin—Ethinyl Estradiol—SHBG—osteoporosis	8.48e-05	0.0478	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—LRP6—osteoporosis	8.4e-05	0.00442	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACP5—osteoporosis	8.37e-05	0.0044	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.26e-05	0.00434	CbGpPWpGaD
Equilin—HSD17B1—Disease—NFATC1—osteoporosis	8.14e-05	0.00428	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR2—osteoporosis	8.12e-05	0.0458	CrCbGaD
Equilin—Estrone—ESR2—osteoporosis	8.1e-05	0.0456	CrCbGaD
Equilin—HSD17B1—Disease—DKK1—osteoporosis	8.08e-05	0.00425	CbGpPWpGaD
Equilin—Estropipate—ESR1—osteoporosis	8.01e-05	0.0452	CrCbGaD
Equilin—HSD17B1—Disease—WNT1—osteoporosis	7.78e-05	0.00409	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TPI1—osteoporosis	7.78e-05	0.00409	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGA—osteoporosis	7.57e-05	0.00398	CbGpPWpGaD
Equilin—Estrone—SHBG—osteoporosis	7.38e-05	0.0416	CrCbGaD
Equilin—HSD17B1—Metabolism—P4HB—osteoporosis	7.31e-05	0.00385	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GAPDH—osteoporosis	7.18e-05	0.00378	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TLN1—osteoporosis	7.09e-05	0.00373	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—RAP1A—osteoporosis	6.99e-05	0.00368	CbGpPWpGaD
Equilin—HSD17B1—Disease—ENO1—osteoporosis	6.75e-05	0.00355	CbGpPWpGaD
Equilin—HSD17B1—Disease—PSMA2—osteoporosis	6.65e-05	0.0035	CbGpPWpGaD
Equilin—HSD17B1—Disease—PSMA5—osteoporosis	6.65e-05	0.0035	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALCA—osteoporosis	6.2e-05	0.00326	CbGpPWpGaD
Equilin—Estradiol—ESR2—osteoporosis	6.14e-05	0.0346	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—P4HB—osteoporosis	6.12e-05	0.00322	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.1e-05	0.00321	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTH—osteoporosis	5.95e-05	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAP1A—osteoporosis	5.85e-05	0.00307	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CNR2—osteoporosis	5.8e-05	0.00305	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—osteoporosis	5.73e-05	0.0323	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—NFATC1—osteoporosis	5.7e-05	0.003	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DKK1—osteoporosis	5.66e-05	0.00298	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO1—osteoporosis	5.65e-05	0.00297	CbGpPWpGaD
Equilin—HSD17B1—Disease—KL—osteoporosis	5.63e-05	0.00296	CbGpPWpGaD
Equilin—Estradiol—SHBG—osteoporosis	5.6e-05	0.0315	CrCbGaD
Equilin—HSD17B1—Metabolism—PSMA5—osteoporosis	5.57e-05	0.00293	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PSMA2—osteoporosis	5.57e-05	0.00293	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—WNT1—osteoporosis	5.45e-05	0.00287	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGA—osteoporosis	5.3e-05	0.00279	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—osteoporosis	5e-05	0.0282	CrCbGaD
Equilin—Estrone—ESR1—osteoporosis	4.99e-05	0.0281	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PTHLH—osteoporosis	4.93e-05	0.00259	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BMP2—osteoporosis	4.93e-05	0.00259	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGB—osteoporosis	4.82e-05	0.00254	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PSMA2—osteoporosis	4.66e-05	0.00245	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PSMA5—osteoporosis	4.66e-05	0.00245	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP19A1—osteoporosis	4.52e-05	0.00238	CbGpPWpGaD
Equilin—HSD17B1—Disease—ADCY5—osteoporosis	4.41e-05	0.00232	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CALCA—osteoporosis	4.34e-05	0.00228	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—osteoporosis	4.05e-05	0.00213	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KL—osteoporosis	3.94e-05	0.00207	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS2—osteoporosis	3.86e-05	0.00203	CbGpPWpGaD
Equilin—Estradiol—ESR1—osteoporosis	3.78e-05	0.0213	CrCbGaD
Equilin—HSD17B1—Metabolism—ADCY5—osteoporosis	3.69e-05	0.00194	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX1—osteoporosis	3.68e-05	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—osteoporosis	3.4e-05	0.00179	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS1—osteoporosis	3.37e-05	0.00177	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6R—osteoporosis	3.16e-05	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADCY5—osteoporosis	3.09e-05	0.00162	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SPP1—osteoporosis	2.99e-05	0.00157	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—POMC—osteoporosis	2.72e-05	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS2—osteoporosis	2.7e-05	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—osteoporosis	2.64e-05	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—osteoporosis	2.52e-05	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS1—osteoporosis	2.36e-05	0.00124	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—POMC—osteoporosis	2.27e-05	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6R—osteoporosis	2.21e-05	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—osteoporosis	2.18e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—osteoporosis	1.87e-05	0.000986	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—osteoporosis	1.87e-05	0.000983	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—osteoporosis	1.41e-05	0.000741	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—osteoporosis	1.31e-05	0.00069	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—osteoporosis	1.31e-05	0.000689	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—osteoporosis	9.87e-06	0.000519	CbGpPWpGaD
